YELP INC·4

Feb 2, 7:19 PM ET

Stoppelman Jeremy 4

4 · YELP INC · Filed Feb 2, 2026

Research Summary

AI-generated summary of this filing

Updated

Yelp CEO Jeremy Stoppelman Exercises Options, Sells 90,000 Shares

What Happened Jeremy Stoppelman, CEO of Yelp (YELP), exercised stock options on Jan 29, Jan 30 and Feb 2, 2026 — 30,000 shares each day (90,000 total) at $20.47 per share (total exercise cost $1,842,300). He concurrently sold the 90,000 shares in open-market transactions under a pre-arranged 10b5-1 plan, generating gross proceeds of about $2,464,350 (weighted-average sale prices on the three dates: $27.35, $27.26 and $27.54). The exercises are reported as derivative conversions (transaction code M) and the sales as open-market disposals (S). Net proceeds before fees and taxes were roughly $622,050.

Key Details

  • Transaction dates and per-date amounts:
    • 2026-01-29: Exercised 30,000 @ $20.47 = $614,100; Sold 30,000 @ weighted avg $27.35 = $820,389 (sales ranged $27.22–$27.57). (Footnotes F1, F2, F5)
    • 2026-01-30: Exercised 30,000 @ $20.47 = $614,100; Sold 30,000 @ weighted avg $27.26 = $817,872 (sales ranged $27.09–$27.39). (Footnotes F1, F3, F5)
    • 2026-02-02: Exercised 30,000 @ $20.47 = $614,100; Sold 30,000 @ weighted avg $27.54 = $826,089 (sales ranged $27.12–$27.64). (Footnotes F1, F4, F5)
  • Total exercised: 90,000 shares at $20.47 ($1,842,300). Total sold: 90,000 shares for ~$2,464,350 (weighted-average prices shown above).
  • Shares owned after the transactions: not specified in this filing.
  • Footnotes of note:
    • F1: Sales were made pursuant to a 10b5-1 trading plan adopted May 19, 2025 (pre-arranged trades).
    • F2–F4: Reported sale prices are weighted averages; each sale occurred in multiple transactions across the price ranges noted above.
    • F5: Options were fully vested.
  • Filing timeliness: the Form 4 does not indicate a late filing.

Context

  • These entries show option exercises followed by immediate open-market sales — effectively a cashless exercise and disposition of the acquired shares. The separate derivative disposal lines at $0 reflect surrender/conversion of the option instruments, which is standard reporting for exercises.
  • Because the sales were executed under a 10b5-1 plan, they were pre-planned trades and are commonly viewed as routine insider liquidity rather than a new sentiment signal.

Insider Transaction Report

Form 4
Period: 2026-01-29
Stoppelman Jeremy
DirectorChief Executive Officer
Transactions
  • Exercise/Conversion

    Common Stock

    2026-01-29$20.47/sh+30,000$614,100786,458 total
  • Sale

    Common Stock

    [F1][F2]
    2026-01-29$27.35/sh30,000$820,389756,458 total
  • Exercise/Conversion

    Common Stock

    2026-01-30$20.47/sh+30,000$614,100786,458 total
  • Sale

    Common Stock

    [F1][F3]
    2026-01-30$27.26/sh30,000$817,872756,458 total
  • Exercise/Conversion

    Common Stock

    2026-02-02$20.47/sh+30,000$614,100786,458 total
  • Sale

    Common Stock

    [F1][F4]
    2026-02-02$27.54/sh30,000$826,089756,458 total
  • Exercise/Conversion

    Stock Option (Right to Buy)

    [F5]
    2026-01-2930,000126,200 total
    Exercise: $20.47Exp: 2026-03-09Common Stock (30,000 underlying)
  • Exercise/Conversion

    Stock Option (Right to Buy)

    [F5]
    2026-01-3030,00096,200 total
    Exercise: $20.47Exp: 2026-03-09Common Stock (30,000 underlying)
  • Exercise/Conversion

    Stock Option (Right to Buy)

    [F5]
    2026-02-0230,00066,200 total
    Exercise: $20.47Exp: 2026-03-09Common Stock (30,000 underlying)
Footnotes (5)
  • [F1]Shares were sold pursuant to a duly adopted 10b5-1 trading plan, adopted by the reporting person on May 19, 2025.
  • [F2]The sales price reported is the weighted average sale price for the number of shares sold. These shares were sold in multiple transactions at prices ranging from $27.22 to $27.57, inclusive. Full information regarding the number of shares sold at each separate price will be supplied upon request by Securities and Exchange Commission Staff, the Issuer or a security holder of the Issuer.
  • [F3]The sales price reported is the weighted average sale price for the number of shares sold. These shares were sold in multiple transactions at prices ranging from $27.09 to $27.39, inclusive. Full information regarding the number of shares sold at each separate price will be supplied upon request by Securities and Exchange Commission Staff, the Issuer or a security holder of the Issuer.
  • [F4]The sales price reported is the weighted average sale price for the number of shares sold. These shares were sold in multiple transactions at prices ranging from $27.12 to $27.64, inclusive. Full information regarding the number of shares sold at each separate price will be supplied upon request by Securities and Exchange Commission Staff, the Issuer or a security holder of the Issuer.
  • [F5]Fully vested.
Signature
/s/ Elizabeth Prosser, Attorney-in-Fact|2026-02-02

Documents

1 file
  • 4
    wk-form4_1770077969.xmlPrimary

    FORM 4